Cocrystal of Naringenin and Norfloxacin: Crystal Transformation, Solubility, and Antibacterial and Anticancer Activities
Crystal Growth & Design · 05.06.2024 · 24 (11) · 4416-4427
DOI: 10.1021/acs.cgd.4c00080 ↗Kurz gefasst
Fachartikel in der Zeitschrift Crystal Growth & Design, online erschienen am 25.05.2024. Verfasst von Xin Zeng und 8 weiteren Autor:innen. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 45 Literaturangaben. Gefördert von: Education Department of Jiangxi Province, National Natural Science Foundation of China, Inherited and Innovative Group of Processing Technique of Traditional Chinese Medicine.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Förderung
- Education Department of Jiangxi Province
- National Natural Science Foundation of China
- Inherited and Innovative Group of Processing Technique of Traditional Chinese Medicine
- Jiangxi University College Students Innovationand Entrepreneurship Project
- Jiangxi Province Traditional Chinese Medicine Administration Project
Zitieren
APA
Zeng, X., Zheng, C., Qiu, S., Jiang, X., Wang, X., Qian, K., Pan, R., Yang, J., & Ma, Y. (2024). Cocrystal of Naringenin and Norfloxacin: Crystal Transformation, Solubility, and Antibacterial and Anticancer Activities. Crystal Growth & Design, 24(11), 4416-4427. https://doi.org/10.1021/acs.cgd.4c00080
Vancouver
Zeng X, Zheng C, Qiu S, Jiang X, Wang X, Qian K, et al. Cocrystal of Naringenin and Norfloxacin: Crystal Transformation, Solubility, and Antibacterial and Anticancer Activities. Crystal Growth & Design. 2024;24(11):4416-4427. doi:10.1021/acs.cgd.4c00080
BibTeX
@article{Zeng2024,
author = {Zeng, Xin and Zheng, Chupei and Qiu, Shouliang and Jiang, Xin and Wang, Xiaoye and Qian, Kun and Pan, Rongbin and Yang, Jie and Ma, Yuexing},
title = {Cocrystal of Naringenin and Norfloxacin: Crystal Transformation, Solubility, and Antibacterial and Anticancer Activities},
journal = {Crystal Growth & Design},
year = {2024},
volume = {24},
number = {11},
pages = {4416--4427},
doi = {10.1021/acs.cgd.4c00080}
}
EUVIMED